Free public records show Nuwacell Biotechnologies Co., Ltd. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Nuwacell Biotechnologies Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
8 active studies led by Nuwacell Biotechnologies Co., Ltd., of 10 in all
Source: ClinicalTrials.gov, Studies with Nuwacell Biotechnologies Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Nuwacell Biotechnologies Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Nuwacell Biotechnologies Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Nuwacell Biotechnologies Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Nuwacell Biotechnologies Co., Ltd. is in.
Stories on the topics Nuwacell Biotechnologies Co., Ltd. works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help…
Read
Breast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to…
ReadSearch all reports for Nuwacell Biotechnologies Co., Ltd. All companies